EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough ...Middle East

News by : (Medscape) -
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough )

Also on site :

Most Viewed News
جديد الاخبار